Clinical Research Directory
Browse clinical research sites, groups, and studies.
BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Sponsor: Braveheart Bio, Inc.
Summary
The main purpose of this trial is to find out whether BHB-1893 works better than metoprolol in adults with symptoms of obstructive hypertrophic cardiomyopathy (oHCM). The trial includes adults who are currently being treated for oHCM or who have not yet been treated.
Official title: A Phase 3, Multi-region, Multi-center, Randomized, Double-blind, Active-Comparator-Controlled Trial to Evaluate the Efficacy and Safety of BHB-1893 Compared to Metoprolol in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
210
Start Date
2026-10
Completion Date
2028-11
Last Updated
2026-08-10
Healthy Volunteers
No
Conditions
Interventions
BHB-1893
Tablets for oral use
Metoprolol
Capsules for oral use